For example, the highest risk for ER-positive BC is associated with ATM, CDH1, and CHEK2, whereas BARD1, BRCA1, BRCA2, PALB2, RAD51C, and RAD51D confer a higher risk for ER-negative BC [73]. This evidence concerns the gene RAD51C and breast cancer.